Here is the question worth sitting with this week: if institutional appetite for AI paper were as deep as the bulls claim, why would Goldman Sachs, Morgan Stanley, and JPMorgan need more time?
Anthropic is now expected to begin marketing its IPO in mid-October at the earliest and complete the listing days before the U.S. midterm elections in November. The company had been expected to make its prospectus public as early as last week, a crucial step that kicks off the final stages of the offering. That is now not expected until late September, with people familiar with the matter cautioning that all plans remain subject to change.
One week of slippage is noise. But framing the delay as routine ignores what the calendar actually says. The listing now lands inside the single most volatile fortnight on the U.S. political calendar. Investment committees that ordinarily price a deal on fundamentals will be doing so while watching Senate race projections. Institutions do not love uncertainty about policy, AI regulation, or either.
The Comparison Nobody Is Making Loudly
SpaceX’s June 2026 IPO was historic. After pricing at $135 per share and raising $75 billion, the stock surged over 67% to a peak north of $225. As of early September, SPCX has been trading around the high $140s, well off its 52-week high of $225.64. That is a company with real revenue, a functioning launch business, and Starlink cash flows. It is still about 34% below its peak, and lockup tranches continue releasing in stages through September 9, September 24, October 9, October 24, and December 8.
Every one of those unlock dates lands during the window Anthropic is trying to price into. Supply coming into the market from SpaceX insiders is not a friendly backdrop for a rival AI deal trying to clear at $2 trillion.
The Valuation Math Is Aggressive
Anthropic’s most recent funding round valued the company at $965 billion, meaning a $2 trillion public-market valuation would represent a substantial increase in just a few months. Some investors are modeling annualized revenue reaching between $100 billion and $120 billion by year-end, but that is investor math, not company guidance. A $2 trillion debut requires deep demand from sovereign wealth funds, large asset managers, and index funds, all of whom have already written large checks into the private rounds and may have limited appetite to step up again at a 2x markup.
As part of the IPO process, Anthropic is working to finalize a $15 billion revolving credit facility, clearing a hurdle before its public filing and roadshow.
What Investors Are Missing
The real second-order question is not whether Anthropic prices successfully. It is what a delayed, election-adjacent pricing does to the IPO that follows it. OpenAI is also expected to list, and Anthropic’s result will frame what institutions are willing to pay for the next deal. If Anthropic prices at a discount to its $2 trillion target, the entire AI listing cycle reprices downward with it.
One slip in an IPO calendar this complex is normal. A second slip that pushes pricing into live midterm-election volatility is the one that would actually worry a sophisticated cap table holder.
Stocks to Watch
- Anthropic (pre-IPO): The deal’s pricing will be the first audited look at frontier AI unit economics. Every assumption baked into AI valuations gets tested here.
- SpaceX (SPCX): October unlock tranches overlap directly with Anthropic’s marketing window. Two AI-adjacent mega-cap supply events in the same fortnight is a genuine crowding risk for institutional buyers.
- Amazon (AMZN): A major backer of Anthropic, including a widely reported $4 billion investment. A strong IPO validates Amazon’s AI infrastructure bet; a cut-price deal raises questions about the return on that capital.
- Microsoft (MSFT): Its deep ties to OpenAI mean an Anthropic stumble would reset expectations for the entire frontier-model investment cycle, directly affecting how the market values Microsoft’s AI revenue.
